Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman D G, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C
Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
BMJ. 2017 Aug 2;358:j3453. doi: 10.1136/bmj.j3453.
While the patient and public involvement (PPI) evidence base has expanded over the past decade, the quality of reporting within papers is often inconsistent, limiting our understanding of how it works, in what context, for whom, and why. To develop international consensus on the key items to report to enhance the quality, transparency, and consistency of the PPI evidence base. To collaboratively involve patients as research partners at all stages in the development of GRIPP2. The EQUATOR method for developing reporting guidelines was used. The original GRIPP (Guidance for Reporting Involvement of Patients and the Public) checklist was revised, based on updated systematic review evidence. A three round Delphi survey was used to develop consensus on items to be included in the guideline. A subsequent face-to-face meeting produced agreement on items not reaching consensus during the Delphi process. 143 participants agreed to participate in round one, with an 86% (123/143) response for round two and a 78% (112/143) response for round three. The Delphi survey identified the need for long form (LF) and short form (SF) versions. GRIPP2-LF includes 34 items on aims, definitions, concepts and theory, methods, stages and nature of involvement, context, capture or measurement of impact, outcomes, economic assessment, and reflections and is suitable for studies where the main focus is PPI. GRIPP2-SF includes five items on aims, methods, results, outcomes, and critical perspective and is suitable for studies where PPI is a secondary focus. GRIPP2-LF and GRIPP2-SF represent the first international evidence based, consensus informed guidance for reporting patient and public involvement in research. Both versions of GRIPP2 aim to improve the quality, transparency, and consistency of the international PPI evidence base, to ensure PPI practice is based on the best evidence. In order to encourage its wide dissemination this article is freely accessible on and journal websites.
尽管患者及公众参与（PPI）的证据基础在过去十年中有所扩展，但论文中的报告质量往往参差不齐，这限制了我们对其运作方式、适用背景、受众群体及原因的理解。为就提高PPI证据基础的质量、透明度和一致性所需报告的关键项目达成国际共识。在GRIPP2的制定过程中，让患者作为研究伙伴共同参与各个阶段。采用了EQUATOR制定报告指南的方法。基于最新的系统评价证据，对最初的GRIPP（患者及公众参与报告指南）清单进行了修订。通过三轮德尔菲调查就指南中应包含的项目达成共识。随后的面对面会议就德尔菲过程中未达成共识的项目达成了一致意见。143名参与者同意参加第一轮调查，第二轮的回复率为86%（123/143），第三轮的回复率为78%（112/143）。德尔菲调查确定了需要长篇（LF）和短篇（SF）版本。GRIPP2-LF包括关于目的、定义、概念和理论、方法、参与阶段和性质、背景、影响的捕捉或测量、结果、经济评估以及反思等34个项目，适用于主要关注PPI的研究。GRIPP2-SF包括关于目的、方法、结果、成果和批判性视角等5个项目，适用于PPI为次要关注点的研究。GRIPP2-LF和GRIPP2-SF代表了首个基于国际证据、经共识形成的关于报告患者及公众参与研究的指南。GRIPP2的两个版本旨在提高国际PPI证据基础的质量、透明度和一致性，确保PPI实践基于最佳证据。为鼓励广泛传播，本文可在 和 期刊网站上免费获取。
